| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/26/2002 | US20020137202 Diagnosis, treatment, and prevention of disorders associated with a FCTRX nucleic acid, polypeptide, or an antibody specific for it |
| 09/26/2002 | US20020137190 High growth methanotrophic bacterial strain |
| 09/26/2002 | US20020137185 Enzymes having amidase activity and methods of use thereof |
| 09/26/2002 | US20020137182 For obtaining and using a polypeptide other than oncogene BCL-2 that affects programmed vertebrate cell death |
| 09/26/2002 | US20020137177 One or more amino acid residues being replaced by cysteine residues where at least some of cysteine residues are modified by replacing thiol hydrogen in cysteine residue with thiol side chain to form modified enzyme |
| 09/26/2002 | US20020137171 Nucleic acid encoding a polypeptide having hydrolase activity |
| 09/26/2002 | US20020137166 ASIP-related proteins |
| 09/26/2002 | US20020137146 Escherichia culture product |
| 09/26/2002 | US20020137145 Human erythropoietin gene: high level expression in stably transfected mammalian cells |
| 09/26/2002 | US20020137142 Tango-73 nucleic acids |
| 09/26/2002 | US20020137138 Modulating serotonin activity |
| 09/26/2002 | US20020137137 Genetic engineering; polypeptides |
| 09/26/2002 | US20020137134 Genetic engineering; glycoproteins |
| 09/26/2002 | US20020137133 Receptor proteins |
| 09/26/2002 | US20020137129 Polypeptides; genetic engineering; drug development |
| 09/26/2002 | US20020137127 Culture product; polypeptides |
| 09/26/2002 | US20020137125 Methods for introducing mannose 6-phosphate and other oligosacharides onto glycoroteins and its application thereof |
| 09/26/2002 | US20020137124 Process for the continuous production of dipeptide crystals in a membrane and hydro-cyclone reactor using a peptidase |
| 09/26/2002 | US20020137119 Immunoassay; quantitative analysis |
| 09/26/2002 | US20020137110 Detecting apoptosis |
| 09/26/2002 | US20020137109 Anticarcinogenic agents;monitoring therapy efficiency |
| 09/26/2002 | US20020137095 Reelin protein CR-50 epitope region |
| 09/26/2002 | US20020137092 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto- immune antibodies |
| 09/26/2002 | US20020137050 Hybrid Dna sequence |
| 09/26/2002 | US20020137038 Intestinal proteins |
| 09/26/2002 | US20020137028 Use of neuronal apoptosis inhibitor protein (naip) |
| 09/26/2002 | US20020136754 Recombinant bacterial phytases and uses thereof |
| 09/26/2002 | US20020136741 Extracting with a polyoxyethylene detergent to deplete inner membranes, extracting remaining outer membranes with zwitterionic betaine dertergent to separate lipooligosaccharides from insoluble factions used for vaccines |
| 09/26/2002 | US20020136730 From coagulase-negative bacteria produced in substantially pure form; use of purified adhesin product as vaccine for production of antibodies effective against binding of homologous bacterial cells to polymeric materials |
| 09/26/2002 | US20020136717 Process for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1 binding domain or a protein having an EVH1 binding domain, and a process for detecting said interaction |
| 09/26/2002 | US20020136695 Human medical treatment by aerosol inhalation of immunoglobulin A |
| 09/26/2002 | US20020136690 Detection and treatment of infections with immunoconjugates |
| 09/26/2002 | CA2852293A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/26/2002 | CA2441902A1 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | CA2441820A1 Evolving new molecular function |
| 09/26/2002 | CA2441388A1 Modified insulin with reduced immunogenicity |
| 09/26/2002 | CA2441095A1 Modified interferon beta with reduced immunogenicity |
| 09/26/2002 | CA2441086A1 Identification of gene expression alterations underlying the aging process in mammals |
| 09/26/2002 | CA2441057A1 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 09/26/2002 | CA2441042A1 Monoclonal antibody therapy for pancreas cancer |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2440028A1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | CA2439916A1 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | CA2438483A1 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | CA2438315A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/26/2002 | CA2425902A1 Urocortin-iii and uses thereof |
| 09/25/2002 | EP1243655A1 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1243650A2 Process for constructing a cdna library, and a polypeptide and dna coding for the same |
| 09/25/2002 | EP1243597A2 Receptors for human interleukin-12 |
| 09/25/2002 | EP1243596A2 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase and methods for identification of inhibitors thereof |
| 09/25/2002 | EP1242823A2 Selecting library members capable of binding to epitopes |
| 09/25/2002 | EP1242611A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 09/25/2002 | EP1242610A1 Method for extractive refolding of scrambledsingle-chain polypeptides |
| 09/25/2002 | EP1242600A1 Cytokine zcyto18 |
| 09/25/2002 | EP1242599A2 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 09/25/2002 | EP1242596A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242459A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 09/25/2002 | EP1242458A2 Brain specific binding members |
| 09/25/2002 | EP1242457A1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2002 | EP1242456A2 Scfv antibodies against disease associated molecules |
| 09/25/2002 | EP1242060A1 Treatment of metastatic disease |
| 09/25/2002 | EP1115852A4 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 09/25/2002 | EP1060184A4 Best's macular dystrophy gene |
| 09/25/2002 | EP0975765A4 Plant fatty acid epoxygenase genes and uses therefor |
| 09/25/2002 | EP0804591B1 Serum paraoxonase |
| 09/25/2002 | EP0696320B1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 09/25/2002 | EP0652966B1 Method of increasing expression of viral proteins |
| 09/25/2002 | CN1371424A Activatable recombinant neurotoxins |
| 09/25/2002 | CN1371423A Gene coding cyclic lipopeptide acrylase and expression of the same |
| 09/25/2002 | CN1371421A Tankyrase 2 materials and methods |
| 09/25/2002 | CN1371415A Fabrication of beta-pleated sheet proteins with specific binding properties |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371389A 疫苗 Vaccine |
| 09/25/2002 | CN1370838A Amidated recombinant polypeptide and its prepn |
| 09/25/2002 | CN1370783A Small molecular lung cancer antibody targeted immunotoxin and its prepn and use |
| 09/25/2002 | CN1370782A Recombinant syphilis spirochete epitope antigen and multiple-epitope chimeric antigen |
| 09/24/2002 | WO2002077203A1 Selection media for beauveriolide i or beauveriolide iii and process for selectively producing these substances |
| 09/24/2002 | US6455755 Leukotriene B4 receptor transgenic mice |
| 09/24/2002 | US6455683 Nucleotidesequences coding protein for use in the prevetion and treatment of infectious, inflammatory and allergic diseases |
| 09/24/2002 | US6455678 Human hematopoietic stem and progenitor cell antigen |
| 09/24/2002 | US6455676 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455498 Structural alterations of the EGF receptor genes in human tumors |
| 09/24/2002 | US6455492 Hepatitis E virus vaccine and method |
| 09/24/2002 | US6455314 Recombinant fiber protein having a trimerization domain and which interacts with adenoviral penton base; for gene transfer methods |
| 09/24/2002 | US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents |
| 09/24/2002 | US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |
| 09/24/2002 | US6455283 Amino acid sequence of polypeptide; for recombinant cell culture production of this growth factor; anticarcinogenic agents; wound healing agents |
| 09/24/2002 | US6455279 Culturing prokaryotic cells transformed with expression vector encoding the polypeptide with a signal sequence and expression vector encoding chaperone protein found in prokaryotes, then cleaving off the signal sequence |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| 09/24/2002 | US6455275 DNA construct for producing proteinaceous materials in eucaryotic cells |
| 09/24/2002 | US6455273 Contacting protein with thiol protease obtainable from germinating soybean cotyledons to produce protein hydrolyzate with reduced bitterness and content of free amino acids, incorporating into food product |
| 09/24/2002 | US6455267 Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases |
| 09/24/2002 | US6455253 Methods and compositions for polypeptide engineering |
| 09/24/2002 | US6455245 For immunoassay detection |